March 11 (Reuters) - Daiichi Sankyo Co Ltd:
* ON MARCH 8, QUIZARTINIB APPROVED TO TREAT ADULT PATIENTS WITH ACUTE MYELOID LEUKAEMIA Source text for Eikon: Further company coverage:
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,010 JPY | +5.12% | +8.07% | +29.39% |
Apr. 25 | Scholz pledges further support for the pharmaceutical industry | DP |
Apr. 25 | Daiichi Sankyo's Attributable Profit Soars 84% in Fiscal 2024 | MT |
March 11 (Reuters) - Daiichi Sankyo Co Ltd:
* ON MARCH 8, QUIZARTINIB APPROVED TO TREAT ADULT PATIENTS WITH ACUTE MYELOID LEUKAEMIA Source text for Eikon: Further company coverage:
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
5,010 JPY | +5.12% | +8.07% | 61.03B | ||
2,686 PTS | +0.86% | +2.29% | - | ||
1st Jan change | Capi. | |
---|---|---|
+29.39% | 61.03B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |